Links Between Serum Amino Acid Levels and Genetic Predisposition to Depression in the LURIC Study
Clinical Scorecard: Links Between Serum Amino Acid Levels and Genetic Predisposition to Depression in the LURIC Study
At a Glance
| Category | Detail |
|---|
| Condition | Major Depression |
| Key Mechanisms | Alterations in amino acid metabolism, particularly within glutamatergic signaling and the tryptophan–kynurenine pathway. |
| Target Population | Patients of German ancestry referred for elective coronary angiography. |
| Care Setting | Monocentric, hospital-based cohort study. |
Key Highlights
- Major depression affects approximately 7.5% of men and 13.6% of women worldwide.
- Cumulative lifetime risk of depression is 20.1% in men and 34.0% in women by age 75.
- Circulating amino acids like glutamate and tryptophan are proposed as biomarkers for depression.
- Findings on amino acid profiles in depression are inconsistent across studies.
- Genetic depression risk scores (GDRS) are associated with all-cause and cardiovascular mortality.
Guideline-Based Recommendations
Diagnosis
- Reliable biomarkers are needed to improve diagnostic classification in mood disorders.
Management
- Monitoring of serum amino acid concentrations may support treatment response.
Monitoring & Follow-up
- Amino acid profiles should be considered in the context of genetic predisposition.
Risks
- Increased genetic liability to depression may correlate with altered amino acid metabolism.
Patient & Prescribing Data
Participants in the LURIC study, primarily with cardiovascular risk factors.
Amino acid concentrations may provide insights into metabolic correlates of genetic depression risk.
Clinical Best Practices
- Consider genetic factors when assessing depression risk in patients.
- Utilize serum amino acid profiling as a potential biomarker in depression research.
Related Resources & Content
